Cargando…
Smoking among inpatients in treatment for substance use disorders: prevalence and effect on mental health and quality of life
BACKGROUND: Smoking is still prevalent among people with substance use disorders. The objective of this study was to investigate the prevalence of smoking among patients in treatment for substance use disorders and to analyze the effect of smoking both at baseline and follow-up on drop-out, mental h...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8112056/ https://www.ncbi.nlm.nih.gov/pubmed/33975577 http://dx.doi.org/10.1186/s12888-021-03252-9 |
_version_ | 1783690620686041088 |
---|---|
author | Lien, Lars Bolstad, Ingeborg Bramness, Jørgen G. |
author_facet | Lien, Lars Bolstad, Ingeborg Bramness, Jørgen G. |
author_sort | Lien, Lars |
collection | PubMed |
description | BACKGROUND: Smoking is still prevalent among people with substance use disorders. The objective of this study was to investigate the prevalence of smoking among patients in treatment for substance use disorders and to analyze the effect of smoking both at baseline and follow-up on drop-out, mental health and quality of life. METHODS: One hundred and twenty-eight inpatients (26% female), mainly with alcohol use disorder, staying at three different rehabilitation clinics in Eastern Norway, were interviewed at admission, and at 6 weeks and 6 months follow-up. The interview contained mental health-related problems, trauma, questions on alcohol and other substances and quality of life. Non-parametric tests were used to test group differences and unadjusted and adjusted linear regression to test the associations between smoking and the main outcome variables, while logistic regression was used to test the association between smoking and drop-out. RESULTS: At admission, 75% were daily smokers. Compared to non-smokers at baseline, the smokers had higher drop-out rates (37% vs. 13%), more mental distress, and lower quality of life from baseline up to 6 months follow-up. Those quitting smoking while admitted improved in mental distress and quality of life at the same rate as non-smokers. Alcohol-related factors did not differ between smokers and non-smokers. CONCLUSIONS: Smoking was associated with mental distress, quality of life and treatment drop-out among patients in primary alcohol use disorder treatment. The results indicate that smoking cessation should be recommended as an integral part of alcohol use treatment both before and during inpatient treatment to reduce drop-out. |
format | Online Article Text |
id | pubmed-8112056 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-81120562021-05-12 Smoking among inpatients in treatment for substance use disorders: prevalence and effect on mental health and quality of life Lien, Lars Bolstad, Ingeborg Bramness, Jørgen G. BMC Psychiatry Research BACKGROUND: Smoking is still prevalent among people with substance use disorders. The objective of this study was to investigate the prevalence of smoking among patients in treatment for substance use disorders and to analyze the effect of smoking both at baseline and follow-up on drop-out, mental health and quality of life. METHODS: One hundred and twenty-eight inpatients (26% female), mainly with alcohol use disorder, staying at three different rehabilitation clinics in Eastern Norway, were interviewed at admission, and at 6 weeks and 6 months follow-up. The interview contained mental health-related problems, trauma, questions on alcohol and other substances and quality of life. Non-parametric tests were used to test group differences and unadjusted and adjusted linear regression to test the associations between smoking and the main outcome variables, while logistic regression was used to test the association between smoking and drop-out. RESULTS: At admission, 75% were daily smokers. Compared to non-smokers at baseline, the smokers had higher drop-out rates (37% vs. 13%), more mental distress, and lower quality of life from baseline up to 6 months follow-up. Those quitting smoking while admitted improved in mental distress and quality of life at the same rate as non-smokers. Alcohol-related factors did not differ between smokers and non-smokers. CONCLUSIONS: Smoking was associated with mental distress, quality of life and treatment drop-out among patients in primary alcohol use disorder treatment. The results indicate that smoking cessation should be recommended as an integral part of alcohol use treatment both before and during inpatient treatment to reduce drop-out. BioMed Central 2021-05-11 /pmc/articles/PMC8112056/ /pubmed/33975577 http://dx.doi.org/10.1186/s12888-021-03252-9 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Lien, Lars Bolstad, Ingeborg Bramness, Jørgen G. Smoking among inpatients in treatment for substance use disorders: prevalence and effect on mental health and quality of life |
title | Smoking among inpatients in treatment for substance use disorders: prevalence and effect on mental health and quality of life |
title_full | Smoking among inpatients in treatment for substance use disorders: prevalence and effect on mental health and quality of life |
title_fullStr | Smoking among inpatients in treatment for substance use disorders: prevalence and effect on mental health and quality of life |
title_full_unstemmed | Smoking among inpatients in treatment for substance use disorders: prevalence and effect on mental health and quality of life |
title_short | Smoking among inpatients in treatment for substance use disorders: prevalence and effect on mental health and quality of life |
title_sort | smoking among inpatients in treatment for substance use disorders: prevalence and effect on mental health and quality of life |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8112056/ https://www.ncbi.nlm.nih.gov/pubmed/33975577 http://dx.doi.org/10.1186/s12888-021-03252-9 |
work_keys_str_mv | AT lienlars smokingamonginpatientsintreatmentforsubstanceusedisordersprevalenceandeffectonmentalhealthandqualityoflife AT bolstadingeborg smokingamonginpatientsintreatmentforsubstanceusedisordersprevalenceandeffectonmentalhealthandqualityoflife AT bramnessjørgeng smokingamonginpatientsintreatmentforsubstanceusedisordersprevalenceandeffectonmentalhealthandqualityoflife |